NCT01900171View on ClinicalTrials.gov

Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Essential Hypertension
Interventions
DRUG

QGC001 [(3S,3'S)-4,4'-dithiobis (3-aminobutane-1-sulfonic acid)]

DRUG

Placebo

Contains magnesium stearate, silica dental type, anhydrous lactose

Trial Locations (1)

92502

Biotrial PARIS, Rueil-Malmaison

All Listed Sponsors
lead

Quantum Genomics SA

INDUSTRY

NCT01900171 - Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo | Biotech Hunter | Biotech Hunter